Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 229 of 5804
-
New drug hope for kids with MS: ublituximab trial launches
Disease control Recruiting nowThe primary purpose of this study is to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of ublituximab in participants ages 10 to less than (\<)18 years and body weight greater than or equal to (≥)25 kilograms (kg) to less than or equal to (≤)40 kg with RMS (Part A) …
Phase: PHASE2, PHASE3 • Sponsor: TG Therapeutics, Inc. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New hope for myeloma patients who relapse after CAR t: bispecific antibody trial launches
Disease control Not yet recruitingThis is a single-center, single-arm, phase 2 study designed to evaluate the efficacy and safety of linvoseltamab in multiple myeloma (MM) patients who relapsed following BCMA CAR T-cell therapy, whether standard of care or investigational.
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Implantable brain device aims to tame Drug-Resistant seizures
Disease control Not yet recruitingThe goal of this clinical trial is to demonstrate the safety and effectiveness of focal cortex stimulation with the EASEE(R) System in a large cohort of subjects with medically refractory focal epilepsy. The main questions it aims to answer are: 1. Is the percentage reduction of…
Phase: NA • Sponsor: Precisis US, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug duo aims to shrink breast tumors before surgery
Disease control Not yet recruitingThis is a prospective, open-label, single-center, randomized controlled Phase II clinical study aimed at evaluating the efficacy and safety of neoadjuvant imlunestrant combined with abemaciclib guided by the Ki67 index after 2 weeks in patients with ER+/HER2- breast cancer.
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Cord tissue patches aim to heal stubborn diabetic foot sores
Disease control Not yet recruitingThe purpose of this study is to evaluate the efficacy of two dehydrated human umbilical cord-based medical devices, also defined as Cellular, Acellular, Matrix-like Products/skin substitutes, plus SOC versus SOC alone in achieving complete closure of hard-to-heal diabetic foot ul…
Phase: NA • Sponsor: StimLabs • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New study to track gene Therapy's Real-World impact on spinal muscular atrophy
Disease control Not yet recruitingThe primary purpose is to address critical evidence in the treatment landscape for Spinal Muscular Atrophy (SMA), specifically focusing on the intrathecal formulation of onasemnogene abeparvovec-brve (ITVISMA®). U.S. Pragmatic Multicenter Study (STREAM).
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope against superbug pneumonia: Dual-Action antibiotic trial launches
Disease control Not yet recruitingStudy on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria.
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New cream after heat treatment may help women with HIV beat HPV
Disease control Not yet recruitingThis randomized, placebo-controlled trial will evaluate self-administered 5-fluorouracil (5FU) to improve human papillomavirus (HPV) clearance after thermal ablation (TA) in Women With Human Immunodeficiency Virus (HIV) (WWH) in Kenya. The trial will also assess the safety, adher…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for severe brain clots: clot removal plus meds vs. meds alone
Disease control Not yet recruitingREVIVE-CVST is a multicenter, prospective, randomized, open-label, blinded-endpoint (PROBE) trial evaluating whether early endovascular thrombectomy (EVT) combined with standard anticoagulation improves outcomes compared to anticoagulation alone in patients with severe cerebral v…
Phase: NA • Sponsor: Middle East North Africa Stroke and Interventional Neurotherapies Organization • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New radiation technique targets stomach and ovarian cancer spread without surgery
Disease control Not yet recruitingThis prospective phase II study evaluates the efficacy and safety of MRI-guided stereotactic body radiotherapy (MRIgSBRT) in patients with oligometastatic peritoneal carcinomatosis from gastrointestinal or gynecological tumors. Eligible patients with up to 5 MRI-visible peritonea…
Phase: PHASE2 • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New pill aims to delay dialysis and save hearts in kidney patients
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled, parallel-group and event-driven phase III clinical trial. The aim of this trial is to confirm the superiority of HRS-7535 over placebo in reducing the risks of renal outcomes and cardiovascular death among parti…
Phase: PHASE3 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Anti-Inflammatory drug may boost cancer therapy in bile duct cancer
Disease control Recruiting nowThis study aims to evaluate whether adding celecoxib to standard therapy can improve clinical outcomes in patients with advanced intrahepatic cholangiocarcinoma. The current standard treatment typically consists of immunotherapy combined with chemotherapy; however, there are sign…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai 6th People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug cocktail aims to tame deadly bile duct cancer
Disease control Not yet recruitingThis is a single-arm, multicenter clinical study designed to evaluate the efficacy and safety of Iparomlimab and Toripalimab (QL1706) in combination with bevacizumab and chemotherapy as first-line treatment for patients with advanced biliary tract cancer
Phase: PHASE4 • Sponsor: Xianglin Yuan • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Virtual reality tested as a calming tool during chemo
Symptom relief Not yet recruitingThis randomized controlled trial aims to evaluate the effectiveness of virtual reality-guided imagery in reducing pain, anxiety, and fatigue among female breast cancer patients undergoing adjuvant chemotherapy. Participants will be randomly assigned to either an intervention grou…
Phase: NA • Sponsor: Thoalfokar Mohammed Al-Obaidi • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New Once-Daily pill aims to tame ADHD symptoms in korean youth
Disease control Not yet recruitingThis is a Phase 3, randomized, double-blind, placebo-controlled, multicenter bridging clinical trial designed to evaluate the efficacy and safety of viloxazine extended-release capsules (AK-D101) compared with placebo in Korean children and adolescents aged 6 to 17 years with att…
Phase: PHASE3 • Sponsor: Alvogen Korea • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Targeted magnetic pulses aim to lift bipolar depression
Symptom relief Not yet recruitingThis study is exploring a new approach to treating depression in people with bipolar disorder (BD). Investigators are testing whether a non-invasive form of brain stimulation can help us understand depressed-to-euthymic mood shifts and their related brain circuits in BD. Investi…
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Could a sublingual tablet repair the Brain's leaky barrier in CADASIL?
Disease control Not yet recruitingThis study is a single-center, prospective, single-arm, self-controlled clinical trial designed to assess the safety and efficacy of edaravone dexborneol sublingual tablets for blood-brain barrier (BBB) dysfunction in patients with CADASIL. The study will enroll approximately 60…
Phase: PHASE2 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Two doses of rituximab before transplant may shield children from Epstein-Barr virus
Disease control Recruiting nowThe goal of this clinical trial is to learn if adding rituximab to the ATG-based Protocol can prevent Epstein-Barr virus (EBV) from reactivating in children who have received an allogeneic haploidentical hematopoietic stem cell transplant. It will also learn about the safety of a…
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could a prebiotic diet boost brain development in preterm babies?
Disease control Not yet recruitingThe purpose of this randomized controlled trial is to evaluate the effect of a structured, high-prebiotic dietary pattern on the neurodevelopmental outcomes of preterm infants. The intervention lasts for 6 months and aims to promote the growth of endogenous beneficial gut bacteri…
Phase: NA • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Can mapping migrant networks help end neglected tropical diseases?
Disease control Recruiting nowNeglected Tropical Diseases (NTDs) are among the most common groups of diseases affecting over one billion people globally and are disproportionately concentrated in remote, underserved, and marginalized communities. Efforts toward NTD elimination have largely relied on preventiv…
Phase: NA • Sponsor: Uwemedimo Friday Ekpo • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC